Incidence of Neuroblastoma After a Screening Program
Open Access
- 1 November 2007
- journal article
- pediatric oncology
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 25 (31) , 4929-4932
Abstract
Purpose: A significant increase in the incidence of neuroblastoma occurred among a 5-year birth cohort (May 1989 to April 1994) during an active urinary screening program for its early detection. We examined the postscreening incidence of neuroblastoma in the subsequent 5-year birth cohort (May 1994 to April 1999), with follow-up to 2002, to determine whether the incidence remained increased. Patients and Methods: We reviewed institutional records of patients diagnosed with neuroblastoma during the period from 1994 to 2002 who were born in 1994 to 1999 in the province of Quebec, as well as in the state of Minnesota and the province of Ontario, regions that had served as controls during the screening interval. We calculated and compared incidence rates during the 1994 to 2002 time period. Results: For the 5-year birth cohort as a whole, the rate of newly diagnosed neuroblastoma was higher in Quebec than in the control populations of Minnesota and Ontario (standardized incidence ratio, 1.34; 95% CI, 1.03 to 1.70). However, in years 4 and 5 of the interval, population-based incidence declined to the same levels as those seen in the control areas. Conclusion: The institution of a urinary screening program for neuroblastoma led to increased awareness of the diagnosis and an elevated rate of diagnosis even after the completion of the screening evaluation. However, this halo effect was transient, with diagnostic rates subsequently decreasing within the range seen in control populations.Keywords
This publication has 12 references indexed in Scilit:
- Screening for breast cancer with mammography2006
- Treatment Complications in Children Diagnosed With Neuroblastoma During a Screening ProgramJournal of Clinical Oncology, 2006
- Neuroblastoma trends in Osaka, Japan, and Great Britain 1970–1994, in relation to screeningInternational Journal of Cancer, 2002
- Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence TrendsJNCI: Journal of the National Cancer Institute, 2002
- Screening of Infants and Mortality Due to NeuroblastomaNew England Journal of Medicine, 2002
- Experience with International Neuroblastoma Staging System and Pathology ClassificationBritish Journal of Cancer, 2002
- Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trialControlled Clinical Trials, 2000
- Compliance in a Screening Program for NeuroblastomaPreventive Medicine, 1998
- A population-based study of the usefulness of screening for neuroblastomaThe Lancet, 1996
- NeuroblastomaJournal of Pediatric Hematology/Oncology, 1992